|
Volumn 107, Issue 5, 2012, Pages 792-793
|
A prospective randomized trial of mosapride vs. placebo in constipation-predominant irritable bowel syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LACTULOSE;
MOSAPRIDE;
MOSAR;
PLACEBO;
UNCLASSIFIED DRUG;
BENZAMIDE DERIVATIVE;
GASTROINTESTINAL AGENT;
MORPHOLINE DERIVATIVE;
SEROTONIN AGONIST;
ABDOMINAL PAIN;
ABSENCE OF SIDE EFFECTS;
ADULT;
BLOATING;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CONSTIPATION;
CONTROLLED STUDY;
DIGITAL RECTAL EXAMINATION;
DOUBLE BLIND PROCEDURE;
FECES ANALYSIS;
FEMALE;
HUMAN;
INTENTION TO TREAT ANALYSIS;
IRRITABLE COLON;
LETTER;
MALE;
PATHOPHYSIOLOGY;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SHORT FORM 36;
STOMACH DISTENSION;
SYMPTOMATOLOGY;
TELECONSULTATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
ADULT;
BENZAMIDES;
CONSTIPATION;
FEMALE;
GASTROINTESTINAL AGENTS;
HUMANS;
IRRITABLE BOWEL SYNDROME;
MALE;
MORPHOLINES;
SEROTONIN RECEPTOR AGONISTS;
|
EID: 84862319235
PISSN: 00029270
EISSN: 15720241
Source Type: Journal
DOI: 10.1038/ajg.2012.26 Document Type: Letter |
Times cited : (11)
|
References (6)
|